Sodium Chloride Injection Recalled for Incomplete Seal and Potential Leakage
B. Braun Medical is recalling 0.9% Sodium Chloride Injection due to possible incomplete container seals that may leak. The recall involves 483,229 bags distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: No illnesses or hospitalizations are reported in the source. This is an FDA Class II recall with a theoretical hazard (incomplete seals 'may' cause leakage) and no confirmed harm, consistent with 'risk-of-harm products where injury has not yet been reported.'
Plain-English summary
B. Braun Medical Inc. is recalling certain batches of 0.9% Sodium Chloride Injection, USP, in 500 mL Excel Plus containers. These products are used for intravenous infusion. The recall affects 483,229 bags distributed nationwide.
The recall is due to lack of sterility assurance. Some batches may have incomplete seals near the port assembly, potentially causing microscopic channel leaks. If the seal is compromised, the product's sterility cannot be assured.
Affected lot numbers are: 0061794230 (exp. 01/31/2024), 0061794232 (exp. 01/31/2024), 0061797779 (exp. 02/29/2024), 0061797780 (exp. 02/29/2024), 0061797781 (exp. 02/29/2024), 0061797783 (exp. 02/29/2024), 0061797784 (exp. 03/31/2024), 0061797785 (exp. 03/31/2024), 0061797786 (exp. 03/31/2024), 0061797787 (exp. 03/31/2024), 0061797788 (exp. 03/31/2024), and 0061809680 (exp. 04/30/2024).
Healthcare facilities, pharmacies, and patients should immediately check for these lot numbers. Inventory from affected lots should not be used. Patients who may have received infusions from these batches should contact their healthcare provider.
The recalled product
- Product
- SODIUM CHLORIDE (SODIUM CHLORIDE)
- Brand
- SODIUM CHLORIDE
- Manufacturer
- B. Braun Medical Inc.
- Category
- Drug — Intravenous Injectable
- Hazard
- incomplete-seal
- leakage
- contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lots: 0061794230 Exp. 01/31/2024
- 0061794232 Exp. 01/31/2024
- 0061797779 Exp. 02/29/2024
- 0061797780 Exp. 02/29/2024
- 0061797781 Exp. 02/29/2024
- 0061797783 Exp. 02/29/2024
- 0061797784 Exp. 03/31/2024
- 0061797785 Exp. 03/31/2024
- 0061797786 Exp. 03/31/2024
- 0061797787 Exp. 03/31/2024
- 0061797788 Exp. 03/31/2024
- 0061809680 Exp. 04/30/2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · SODIUM CHLORIDE
- SevereFDA Class I Recall: B. Braun Sodium Chloride Injection for Particulate Matter
FDA (Drugs) · 2024-08-28
- ModerateIntravenous Sodium Chloride Injection Recalled for Incomplete Labeling and Warnings
FDA (Drugs) · 2023-08-16
- HighSodium Chloride Injection Bags Recalled for Potential Leakage and Sterility Risk
FDA (Drugs) · 2023-07-19
- HighSodium Chloride Injection Recalled Due to Storage Temperature Exposure Risk
FDA (Drugs) · 2023-06-07
- HighFDA Recalls Sodium Chloride Injection Due to Incomplete Container Seals
FDA (Drugs) · 2023-03-01
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereErythromycin Tablets Recalled for Impurity Above Acceptable Limits
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27